Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

September 30, 2008

Conditions

Adverse EventsPharmacokinetic Variables

Interventions

DRUG

ABT-143

once

DRUG

ABT-335 and rosuvastatin

once

Trial Locations (1)

Site Reference ID/Investigator# 11101, Evansville